Tesofensine posts mixed cardiometabolic signal in independent meta-analysis

· Trials · Trials Desk

Pooled data from 7 trials show consistent weight loss but heterogeneous effects on resting heart rate and lipid markers.

This brief is part of the Novusyn Research news desk. We track peptide clinical readouts, regulatory actions, and pharma developments in neutral, evidence-led language for scientifically literate readers.

For related context, see the full news desk, clinical trials tracker, regulation tracker, compound directory, and guides library.